Sensus Healthcare Inc (SRTS)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -2.421 | -19.644 | -7.768 | -4.845 | -21.055 | 13.673 | 54.496 | 0.878 |
Return on Equity (%) | -3.265 | -27.536 | -10.608 | -6.243 | -27.622 | 17.339 | 65.45 | 1.001 |
Return on Invested Capital (%) | -2.664 | -25.856 | -9.472 | -6.894 | -32.771 | 17.735 | 31.143 | -1.09 |
Operating Margin (%) | -2.188 | -17.69 | -7.061 | -6.236 | -71.233 | 15.239 | 62.858 | 2.672 |
Net Profit Margin (%) | -2.336 | -18.025 | -7.655 | -6.236 | -71.379 | 15.232 | 54.442 | 1.987 |
Book Value Per Share | 1.081 | 0.827 | 1.615 | 1.678 | 1.283 | 1.557 | 2.93 | 2.981 |
Earnings Per Share | -0.026 | -0.275 | -0.126 | -0.103 | -0.415 | 0.248 | 1.479 | 0.03 |
Cash Per Share | 0.372 | 0.748 | 0.775 | 0.491 | 0.904 | 0.874 | 1.557 | 1.413 |
Working Capital Per Share | 0.967 | 0.965 | 1.606 | 1.67 | 1.232 | 1.521 | 2.779 | 2.766 |
Operating Profit Per Share | 0.752 | 1.052 | 1.09 | 1.098 | 0.362 | 1.059 | 1.827 | 0.875 |
EBIT Per Share | -0.026 | -0.275 | -0.126 | -0.103 | -0.415 | 0.248 | 1.708 | 0.04 |
EBITDA Per Share | -0.026 | -0.275 | -0.126 | -0.103 | -0.415 | 0.248 | 1.708 | 0.04 |
Free Cash Flow Per Share | -0.029 | -0.283 | -0.113 | -0.112 | -0.436 | 0.219 | 1.47 | 0.027 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 13,55M | 13,49M | 16,11M | 16,49M | 16,49M | 16,62M | 16,39M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 16,6M | 16,39M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -78.969 | N/A | N/A | N/A | 29.082 | N/A |
Net Profit Margin (%) | N/A | N/A | -55.477 | N/A | N/A | N/A | 21.326 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 107,68M |
Ratio cours/bénéfice | 219,59 |
Ratio prix/ventes | 4,37 |
Ratio prix/liquidités | 4,6 |
Ratio prix/valeur comptable | 2,18 |
Rendement de dividende | - |
Actions en circulation | 16,39M |
Volume moyen (1 semaine) | 105,23k |
Volume moyen (1 mois) | 83,29k |
Variation sur 52 semaines | 197,05% |
Plus haut sur 52 semaines | 7,18 |
Plus bas sur 52 semaines | 1,79 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales